These pathological alterations reflect the gradual progression of HCC in the edn1 transgenic zebrafish, from steatosis to fibrosis, hyperplasia, and to HCC within 6 months (between 5 and 11 months of age). This evidence concerns the gene EDN1 and hepatocellular carcinoma.